119 related articles for article (PubMed ID: 9508195)
1. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Morris M; Blessing JA; Monk BJ; McGehee R; Moore DH
J Clin Oncol; 2004 Aug; 22(16):3340-4. PubMed ID: 15310778
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
Lacava JA; Leone BA; Machiavelli M; Romero AO; Perez JE; Elem YL; Ferreyra R; Focaccia G; Suttora G; Salvadori MA; Cuevas MA; Acuña LR; Acuña JR; Langhi M; Amato S; Castaldi J; Arroyo A; Vallejo CT
J Clin Oncol; 1997 Feb; 15(2):604-9. PubMed ID: 9053483
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Muggia FM; Blessing JA; Method M; Miller DS; Johnson GA; Lee RB; Menzin A;
Gynecol Oncol; 2004 Feb; 92(2):639-43. PubMed ID: 14766259
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
Muggia FM; Blessing JA; Waggoner S; Berek JS; Monk BJ; Sorosky J; Pearl ML
Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588
[TBL] [Abstract][Full Text] [Related]
7. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.
Conroy T; Etienne PL; Adenis A; Wagener DJ; Paillot B; François E; Bedenne L; Jacob JH; Seitz JF; Bleiberg H; Van Pottelsberghe C; Van Glabbeke M; Delgado FM; Merle S; Wils J
J Clin Oncol; 1996 Jan; 14(1):164-70. PubMed ID: 8558192
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study.
Lhommé C; Vermorken JB; Mickiewicz E; Chevalier B; Alvarez A; Mendiola C; Pawinski A; Lentz MA; Pecorelli S
Eur J Cancer; 2000 Jan; 36(2):194-9. PubMed ID: 10741277
[TBL] [Abstract][Full Text] [Related]
11. An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Degardin M; Oliveira J; Geoffrois L; Rolland F; Armand JP; Bastit P; Chauvergne J; Fargeot P; van Glabbeke M; Lentz MA; Tresca P; Boudillet J; Fumoleau P; Cappelaere P
Ann Oncol; 1998 Oct; 9(10):1103-7. PubMed ID: 9834823
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Saxman S; Mann B; Canfield V; Loehrer P; Vokes E
Am J Clin Oncol; 1998 Aug; 21(4):398-400. PubMed ID: 9708641
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barnes W; Ball H
Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Rose PG; Blessing JA; Arseneau J
Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
[TBL] [Abstract][Full Text] [Related]
16. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
Verschraegen CF; Levy T; Kudelka AP; Llerena E; Ende K; Freedman RS; Edwards CL; Hord M; Steger M; Kaplan AL; Kieback D; Fishman A; Kavanagh JJ
J Clin Oncol; 1997 Feb; 15(2):625-31. PubMed ID: 9053486
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients.
Barth C; Naveau L; Touboul E; Périé S; Bamogho E; Haberer-Guillerm S; Schlienger M; Lacau St Guily J; Huguet F
Anticancer Drugs; 2016 Apr; 27(4):349-52. PubMed ID: 26736136
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
